Humana Inc . (NYSE:HUM), a leading player in the U.S. healthcare sector, is navigating a complex landscape of challenges and opportunities as it seeks to maintain its strong position in the Medicare ...

Health insurance company Humana (NYSE:HUM) announced in Q4 CY2024, with sales up 13.5% year on year to $29.21 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in ...

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new strategies, and market outlook.

Humana reported a Q4 revenue beat at $29.19 billion but saw an adjusted EPS loss. The insurer forecasts 2025 sales of up to $128 billion and a 10% Medicare Advantage decline.

Trading volume stands at 334,823, with HUM's price down by -1.33%, positioned at $256.57. RSI indicators show the stock to be may be approaching oversold.

Humana expects Medicare Advantage members to decline in 2025, following a downgrade to the quality rating of one of its biggest plans. The health insurer reported fourth-quarter revenue that ...

Humana has officially listed its iconic tower in downtown Louisville for sale one year after announcing plans to consolidate staff into its other downtown locations. Humana assures that it remains ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25 ...

LOUISVILLE, Ky. (WDRB) -- Humana plans to list its iconic, 27-story headquarters at 500 W. Main St. in downtown Louisville for sale. In February 2024, the state's only Fortune 500 company ...

Humana Inc . (NYSE:HUM), a leading player in the U.S. healthcare sector, is navigating a complex landscape of challenges and opportunities as it seeks to maintain its strong position in the ...